Small-cell lung cancer (SCLC). initially exquisitely sensitive to first-line cisplatin/etoposide. invariably relapses and acquires a multidrug chemoresistant phenotype that generally renders retreatment with first-line therapy both futile and counterproductive. This report presents the case of a 77-year-old Caucasian male with extensive-stage refractory SCLC who was restarted on plati... https://foldlyers.shop/product-category/new-york-collection/